182 related articles for article (PubMed ID: 33242335)
21. An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ; Maffucci T
Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
[TBL] [Abstract][Full Text] [Related]
22. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
23. Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1.
Laurent PA; Severin S; Gratacap MP; Payrastre B
Adv Biol Regul; 2014 Jan; 54():162-74. PubMed ID: 24095650
[TBL] [Abstract][Full Text] [Related]
24. Class II PI3K Functions in Cell Biology and Disease.
Gulluni F; De Santis MC; Margaria JP; Martini M; Hirsch E
Trends Cell Biol; 2019 Apr; 29(4):339-359. PubMed ID: 30691999
[TBL] [Abstract][Full Text] [Related]
25. A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate.
Zhang J; Banfić H; Straforini F; Tosi L; Volinia S; Rittenhouse SE
J Biol Chem; 1998 Jun; 273(23):14081-4. PubMed ID: 9603905
[TBL] [Abstract][Full Text] [Related]
26. Ligand-Biased Regulation of PtdIns(3,4,5)P3-Dependent Signal Transduction in GPCR Control of Pituitary Hormone Release.
Pemberton JG; Chang JP
Endocrinology; 2017 Feb; 158(2):378-401. PubMed ID: 27906555
[TBL] [Abstract][Full Text] [Related]
27. Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice.
Min SH; Suzuki A; Stalker TJ; Zhao L; Wang Y; McKennan C; Riese MJ; Guzman JF; Zhang S; Lian L; Joshi R; Meng R; Seeholzer SH; Choi JK; Koretzky G; Marks MS; Abrams CS
Nat Commun; 2014 Sep; 5():4691. PubMed ID: 25178411
[TBL] [Abstract][Full Text] [Related]
28. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets.
Banfić H; Tang X; Batty IH; Downes CP; Chen C; Rittenhouse SE
J Biol Chem; 1998 Jan; 273(1):13-6. PubMed ID: 9417038
[TBL] [Abstract][Full Text] [Related]
29. Phosphoinositide 3-kinases as accelerators and brakes of autophagy.
O Farrell F; Rusten TE; Stenmark H
FEBS J; 2013 Dec; 280(24):6322-37. PubMed ID: 23953235
[TBL] [Abstract][Full Text] [Related]
30. Type I phosphoinositide 3-kinases: potential antithrombotic targets?
Jackson SF; Schoenwaelder SM
Cell Mol Life Sci; 2006 May; 63(10):1085-90. PubMed ID: 16649145
[TBL] [Abstract][Full Text] [Related]
31. Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency.
Compton LM; Ikonomov OC; Sbrissa D; Garg P; Shisheva A
Am J Physiol Cell Physiol; 2016 Sep; 311(3):C366-77. PubMed ID: 27335171
[TBL] [Abstract][Full Text] [Related]
32. Essential role of class II PI3K-C2α in platelet membrane morphology.
Valet C; Chicanne G; Severac C; Chaussade C; Whitehead MA; Cabou C; Gratacap MP; Gaits-Iacovoni F; Vanhaesebroeck B; Payrastre B; Severin S
Blood; 2015 Aug; 126(9):1128-37. PubMed ID: 26109204
[TBL] [Abstract][Full Text] [Related]
33. In-depth PtdIns(3,4,5)P
Durrant TN; Hutchinson JL; Heesom KJ; Anderson KE; Stephens LR; Hawkins PT; Marshall AJ; Moore SF; Hers I
Blood Adv; 2017 Jun; 1(14):918-932. PubMed ID: 29242851
[TBL] [Abstract][Full Text] [Related]
34. Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions.
Gratacap MP; Guillermet-Guibert J; Martin V; Chicanne G; Tronchère H; Gaits-Iacovoni F; Payrastre B
Adv Enzyme Regul; 2011; 51(1):106-16. PubMed ID: 21035500
[TBL] [Abstract][Full Text] [Related]
35. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B.
Lova P; Paganini S; Hirsch E; Barberis L; Wymann M; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2003 Jan; 278(1):131-8. PubMed ID: 12407113
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks.
Malik N; Macartney T; Hornberger A; Anderson KE; Tovell H; Prescott AR; Alessi DR
Biochem J; 2018 Jan; 475(1):117-135. PubMed ID: 29150437
[TBL] [Abstract][Full Text] [Related]
37. PI3K signalling in inflammation.
Hawkins PT; Stephens LR
Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
[TBL] [Abstract][Full Text] [Related]
38. Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation.
Selvadurai MV; Moon MJ; Mountford SJ; Ma X; Zheng Z; Jennings IG; Setiabakti NM; Iman RP; Brazilek RJ; Z Abidin NA; Chicanne G; Severin S; Nicholls AJ; Wong CHY; Rinckel JY; Eckly A; Gachet C; Nesbitt WS; Thompson PE; Hamilton JR
Sci Transl Med; 2020 Jul; 12(553):. PubMed ID: 32718993
[TBL] [Abstract][Full Text] [Related]
39. Class II Phosphoinositide 3-Kinases as Novel Drug Targets.
Falasca M; Hamilton JR; Selvadurai M; Sundaram K; Adamska A; Thompson PE
J Med Chem; 2017 Jan; 60(1):47-65. PubMed ID: 27644332
[TBL] [Abstract][Full Text] [Related]
40. Regulation of platelet plug formation by phosphoinositide metabolism.
Min SH; Abrams CS
Blood; 2013 Aug; 122(8):1358-65. PubMed ID: 23757731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
